ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Business Update

Suven Life Sciences Business Update

Suven Life Sciences will present seven posters on its CNS pipeline at Neuroscience 2026, Washington DC. Presentations span Phase-3 and preclinical candidates targeting neurodegenerative and neuropsychiatric disorders.

Source

BSE filing, NSE: SUVEN. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Suven Life Sciences Ltd: key numbers

Share price
₹280.00
Market cap
₹7,912 Cr
Revenue (annual)
₹7.11 Cr
Net profit (annual)
₹-276.3 Cr
P/E (TTM)
-20.7×Sector 54.5×
Promoter holding
65.47%-4.61% QoQ
FII holding
0.45%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Suven Life Sciences Ltd

All →

Other business update announcements

All →